Brief: Flerie's Lipum Presents Final Results From Phase I Trial Of Sol-116
14/04/2025 07:18
April 14 (Reuters) - Flerie AB FLERIE.ST: LIPUM PRESENTS FINAL RESULTS FROM PHASE I TRIAL OF SOL-116 SOL-116 WAS WELL TOLERATED ACROSS ALL DOSE LEVELS, WITH NO SERIOUS ADVERSE EVENTS DEEMED RELATED TO INVESTIGATIONAL DRUG Source text: ID:nMFNbynqwX Further company coverage: FLERIE.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))